TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34340637

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (n = 18)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Computerized cognitive training (n = 18)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Sequential combination of aerobic exercise and computerized cognitive training (n = 20)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control (Aerobic exercise or cognitive training alone)
Number of subjects: 56
Study: 32009435

Group type: EXPERIMENTAL
Intervention: Suture Button (SB)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Syndesmotic Screw (SS)
Number of subjects: 97
Study: 37932788

Group type: EXPERIMENTAL
Intervention: Etelcalcetide (ETEL)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Alfacalcidol (ALFA)
Number of subjects: 62
Study: 33483093

Group type: EXPERIMENTAL
Intervention: Single session treatment
Number of subjects: 53

Group type: COMPARATOR
Intervention: Weekly treatment
Number of subjects: 53
Study: 34146225

Group type: EXPERIMENTAL
Intervention: Web-based facial analysis tool (3D model)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Direct measurements on human subjects' faces
Number of subjects: 16

Group type: COMPARATOR
Intervention: Measurements on 2D photographs
Number of subjects: 16

Group type: COMPARATOR
Intervention: Measurements on 3D models of face scans
Number of subjects: 16
Study: 32492920

Group type: EXPERIMENTAL
Intervention: Manual Lymph Drainage (MLD)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Abdominal Massage (AM)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Electrical Stimulation (ES)
Number of subjects: 52
Study: 35620984

Group type: EXPERIMENTAL
Intervention: Catheter-directed thrombolysis (CDT)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Standard anticoagulation
Number of subjects: 23
Study: 33894838

Group type: EXPERIMENTAL
Intervention: Cagrilintide 1.2 mg with semaglutide 2.4 mg
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Cagrilintide 2.4 mg with semaglutide 2.4 mg
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Cagrilintide 4.5 mg with semaglutide 2.4 mg
Number of subjects: 96

Group type: COMPARATOR
Intervention: Cagrilintide (0.16–4.5 mg) and semaglutide 2.4 mg
Number of subjects: 96
Study: 32363926

Group type: EXPERIMENTAL
Intervention: Tropicana 50 (TRP50)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Kroger low-calorie OJ (KLCO)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Crystal light lemonade beverage (CLLB)
Number of subjects: 10
Study: 34353065

Group type: EXPERIMENTAL
Intervention: Floating needle therapy combined with acupoint embedding
Number of subjects: 64

Group type: COMPARATOR
Intervention: Midodrine combined with Kegel training
Number of subjects: 64
Study: 35241140

Group type: EXPERIMENTAL
Intervention: m-health-based exercise (via guidance plus education)
Number of subjects: 40

Group type: COMPARATOR
Intervention: m-health-based exercise (via guidance)
Number of subjects: 40
Study: 33227510

Group type: EXPERIMENTAL
Intervention: Self-guided internet-delivered pain management program (PMP)
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Optional-guided internet-delivered pain management program (PMP)
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Clinician-guided internet-delivered pain management program (PMP)
Number of subjects: 490
Study: 33969958

Group type: EXPERIMENTAL
Intervention: 10 sets of resistance training (10‐SET)
Number of subjects: 15

Group type: COMPARATOR
Intervention: 5 sets of resistance training (5‐SET)
Number of subjects: 15
Study: 33907903

Group type: EXPERIMENTAL
Intervention: Food Assistance Programs (FAPs)
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Informal food resources
Number of subjects: 329
Study: 35894422

Group type: EXPERIMENTAL
Intervention: Modifications in the school environment (painting of hopscotch and school courts, provision of sports equipment)
Number of subjects: 975

Group type: COMPARATOR
Intervention: Control group (no modifications)
Number of subjects: 975
Study: 32456097

Group type: EXPERIMENTAL
Intervention: Feelbreathe® device (FB group)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Oronasal breathing without FB (ONB group)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 16
Study: 34052372

Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control (no PRP)
Number of subjects: 38
Study: 33031557

Group type: EXPERIMENTAL
Intervention: Intermittent Fasting 70% (IF70)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Intermittent Fasting 70% (IF70) and Intermittent Fasting 100% (IF100)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Intermittent Fasting groups (IF70 and IF100)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Caloric Restriction 70% (CR70)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Intermittent Fasting 100% (IF100)
Number of subjects: 76
Study: 35148742

Group type: EXPERIMENTAL
Intervention: Matched care physiotherapy intervention
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Illness Perceptions (IPs)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Personal control
Number of subjects: 9
Study: 32543422

Group type: EXPERIMENTAL
Intervention: Home yard-size (measured in hectares)
Number of subjects: 531

Group type: EXPERIMENTAL
Intervention: Previous year MVPA (adjusted for direct-effect association)
Number of subjects: 531
Study: 35855557

Group type: EXPERIMENTAL
Intervention: Vorapaxar
Number of subjects: 26449

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26449
Study: 33651908

Group type: EXPERIMENTAL
Intervention: High ligation (HL)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Low ligation (LL)
Number of subjects: 95
Study: 32685097

Group type: EXPERIMENTAL
Intervention: Mulberry milk (10 g)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo milk (50 mL)
Number of subjects: 46
Study: 34983438

Group type: EXPERIMENTAL
Intervention: Caregiver reported family functioning
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Caregiver employment status
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Caregiver hopefulness
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Caregiver burden measurement using Burden Assessment Scale
Number of subjects: 65
Study: 34006923

Group type: EXPERIMENTAL
Intervention: Low-fat dietary intervention
Number of subjects: 48835

Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 48835
Study: 37199879

Group type: EXPERIMENTAL
Intervention: High adherence (MMAS-8 score of 8)
Number of subjects: 1214

Group type: EXPERIMENTAL
Intervention: Increase in MMAS-8 score by 2 points among participants with baseline score ≤ 6
Number of subjects: 1214
Study: 34766214

Group type: EXPERIMENTAL
Intervention: mini percutaneous nephrolithotomy (mPNL)
Number of subjects: 120

Group type: COMPARATOR
Intervention: retrograde intrarenal surgery (RIRS)
Number of subjects: 120
Study: 32592589

Group type: EXPERIMENTAL
Intervention: haloperidol
Number of subjects: 1000

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1000
Study: 35191639

Group type: EXPERIMENTAL
Intervention: Bilateral lumbar ultrasound-guided erector spinae plane block (ESPB) with 0.375% ropivacaine 40 mL
Number of subjects: 60

Group type: COMPARATOR
Intervention: Local infiltration with 0.375% ropivacaine 40 mL
Number of subjects: 60
Study: 33710764

Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus chemotherapy (combination therapy group)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Pembrolizumab monotherapy (monotherapy group)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Patients with PD-L1 TPS ≥50% in combination therapy group
Number of subjects: 71

Group type: COMPARATOR
Intervention: Patients with PD-L1 TPS ≥50% in monotherapy group
Number of subjects: 71
Study: 33072215

Group type: EXPERIMENTAL
Intervention: Cooperative flipped learning method
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Individual flipped learning method
Number of subjects: 61

Group type: COMPARATOR
Intervention: Conventional method (Control)
Number of subjects: 61
Study: 33947416

Group type: EXPERIMENTAL
Intervention: Whole-body vibration training (WBV) on a vibration platform (Galileo) at varying frequencies (5–26 Hz)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Whole-body vibration training (WBV)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional balance training (BAL)
Number of subjects: 48
Study: 32268601

Group type: EXPERIMENTAL
Intervention: Brain Breaks videos (10 min in duration) shared through a WhatsApp group
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 70
Study: 35964870

Group type: EXPERIMENTAL
Intervention: Phase-specific brain stimulation targeting mu rhythm (0°, 90°, 180°, 270°) with TMS
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Phase-specific brain stimulation targeting beta rhythm (0°, 90°, 180°, 270°) with TMS
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mu power
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Beta power
Number of subjects: 20
Study: 32305995

Group type: EXPERIMENTAL
Intervention: Probiotics (Lactobacillus rhamnosus, LGG® and Bifidobacterium animalis spp. lactis, BB‐12®) for 6 months
Number of subjects: 186

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 186
Study: 32157582

Group type: EXPERIMENTAL
Intervention: Exercise and PBM active group (n=16)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Exercise and PBM placebo group (n=17)
Number of subjects: 34
Study: 33002672

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab (IVB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab (IVR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept (IVA)
Number of subjects: 0
Study: 33028236

Group type: EXPERIMENTAL
Intervention: MS Spasticity: Take Control (STC) program
Number of subjects: 220

Group type: COMPARATOR
Intervention: Control program (NMSS brochure)
Number of subjects: 220
Study: 36178197

Group type: EXPERIMENTAL
Intervention: Bexagliflozin 20 mg
Number of subjects: 426
Study: 32883164

Group type: EXPERIMENTAL
Intervention: Ultrasound guided (USG) cannulation
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard cannulation (no USG)
Number of subjects: 32
Study: 36148625

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM) powder
Number of subjects: 80

Group type: COMPARATOR
Intervention: Gauze padding containing furacilin
Number of subjects: 80
Study: 32614733

Group type: EXPERIMENTAL
Intervention: Biomechanical risk factors evaluation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ergonomic interventions
Number of subjects: 20
Study: 33647122

Group type: EXPERIMENTAL
Intervention: 40% deet (Bushman™)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 31.2% metofluthrin (OFF!® Clip‐On™)
Number of subjects: 0
Study: 34326294

Group type: EXPERIMENTAL
Intervention: Greater occipital nerve stimulation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Trigeminal stimulation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: GON stimulation with capsaicin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Trigeminal stimulation on V1
Number of subjects: 40
Study: 33762145

Group type: EXPERIMENTAL
Intervention: High-dose coaching with ECHO
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: High-dose coaching without ECHO
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Low-dose coaching with ECHO
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Low-dose coaching without ECHO
Number of subjects: 48
Study: 34757700

Group type: EXPERIMENTAL
Intervention: Persian metabolic diet (PMD)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Optional diet (OD)
Number of subjects: 56
Study: 33557035

Group type: EXPERIMENTAL
Intervention: CE+HCO3 group (carbohydrate-electrolyte solution with bicarbonate)
Number of subjects: 16

Group type: COMPARATOR
Intervention: TW group (tap water)
Number of subjects: 16
Study: 34255812

Group type: EXPERIMENTAL
Intervention: Activating motor imagery (MI)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Relaxing motor imagery (MI)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study: 32540321

Group type: EXPERIMENTAL
Intervention: Perioperative Dexamethasone (DEX) for 3 days
Number of subjects: 93

Group type: COMPARATOR
Intervention: No Dexamethasone (NON-DEX)
Number of subjects: 93
Study: 32304519

Group type: EXPERIMENTAL
Intervention: RPE (session rating of perceived exertion)
Number of subjects: 20

Group type: COMPARATOR
Intervention: PP (predetermined progression method)
Number of subjects: 20
Study: 32458501

Group type: EXPERIMENTAL
Intervention: Semisolid nutrients
Number of subjects: 5331

Group type: COMPARATOR
Intervention: Liquid nutrients
Number of subjects: 5331
Study: 32603172

Group type: EXPERIMENTAL
Intervention: Single-qubit rotation gates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two-qubit controlled-Z gate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single-qubit geometric gates
Number of subjects: 0
Study: 35455245

Group type: EXPERIMENTAL
Intervention: MF59-adjuvanted, H5N1 influenza pandemic vaccine (aH5N1c), two doses administered 21 days apart
Number of subjects: 3196

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3196

Group type: EXPERIMENTAL
Intervention: MF59-adjuvanted, H5N1 influenza pandemic vaccine (aH5N1c)
Number of subjects: 3196
Study: 33158412

Group type: EXPERIMENTAL
Intervention: Clinic-based recruitment
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Letters to patients from electronic databases
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Patient portal
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Multiple recruitment strategies
Number of subjects: 231
Study: 36158118

Group type: EXPERIMENTAL
Intervention: Improved oral care method (oral scrubbing before intubation, brushing and washing after intubation, 3 times per day, using 0.1% povidone-iodine in oral care solution)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine oral care (scrubbing 3 times per day, using physiological brine)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Improved oral care method
Number of subjects: 100
Study: 34374343

Group type: EXPERIMENTAL
Intervention: MATRIX score (age, height, smoking, renal failure, prior coronary artery bypass grafting, ST-segment elevation myocardial infarction, Killip class, radial expertise)
Number of subjects: 4197

Group type: EXPERIMENTAL
Intervention: MATRIX score
Number of subjects: 4197
Study: 33108925

Group type: EXPERIMENTAL
Intervention: Palliative sedation (midazolam)
Number of subjects: 125
Study: 35603652

Group type: EXPERIMENTAL
Intervention: Xinfeng Capsule (XFC)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Leflunomide (LEF)
Number of subjects: 80
Study: 33683315

Group type: EXPERIMENTAL
Intervention: Family Navigation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 33472450

Group type: EXPERIMENTAL
Intervention: Sorafenib
Number of subjects: 68

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 68
Study: 32517584

Group type: EXPERIMENTAL
Intervention: General Anesthesia (GA)
Number of subjects: 4429

Group type: COMPARATOR
Intervention: Conscious Sedation (CS)
Number of subjects: 4429

Group type: EXPERIMENTAL
Intervention: Local Anesthesia (LA)
Number of subjects: 4429
Study: 36281767

Group type: EXPERIMENTAL
Intervention: Precuneus rTMS
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 50
Study: 615917865

Group type: EXPERIMENTAL
Intervention: ZCB00V
Number of subjects: 15

Group type: COMPARATOR
Intervention: PY‐60AD
Number of subjects: 15
Study: 33857238

Group type: EXPERIMENTAL
Intervention: Musical Improvisation (MI) group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hands-Busy (HB) group
Number of subjects: 0
Study: 36174746

Group type: EXPERIMENTAL
Intervention: MomMoodBooster2 program (eHealth group)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Routine care (routine-care group)
Number of subjects: 191
Study: 32740293

Group type: EXPERIMENTAL
Intervention: Repetitions to failure (RF)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Repetitions not to failure (NRF)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-exercise control (Con)
Number of subjects: 20
Study: 32242973

Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 35945493

Group type: EXPERIMENTAL
Intervention: Care management intervention with a care manager, including 6 to 8 telephone contacts over 12 weeks
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Care management intervention
Number of subjects: 376

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 376
Study: 33732655

Group type: EXPERIMENTAL
Intervention: Maternal antibiotic usage
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Maternal probiotic usage
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Infant probiotic intake
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Breastmilk feeding
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Lower socioeconomic status (SES)
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Hospital of birth
Number of subjects: 227
Study: 32227774

Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 70

Group type: COMPARATOR
Intervention: Sham Acupressure
Number of subjects: 70
Study: 36052499

Group type: EXPERIMENTAL
Intervention: Manual therapy and common medication
Number of subjects: 24

Group type: COMPARATOR
Intervention: Common medication only
Number of subjects: 24
Study: 32338445

Group type: EXPERIMENTAL
Intervention: HOPE service (brief psychological therapy)
Number of subjects: 89
Study: 33277507

Group type: EXPERIMENTAL
Intervention: tiotropium/olodaterol (5/5 µg) via Respimat® inhaler
Number of subjects: 3100

Group type: COMPARATOR
Intervention: monocomponents via Respimat® inhaler
Number of subjects: 3100
Study: 35189093

Group type: EXPERIMENTAL
Intervention: 200 mg vaginal progesterone suppository nightly from 16 to 36 weeks of gestation
Number of subjects: 205

Group type: COMPARATOR
Intervention: 250 mg intramuscular 17-hydroxyprogesterone caproate weekly from 16 to 36 weeks of gestation
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: 200 mg vaginal progesterone suppository nightly
Number of subjects: 205

Group type: COMPARATOR
Intervention: 250 mg intramuscular 17-hydroxyprogesterone caproate weekly
Number of subjects: 205
Study: 33559260

Group type: COMPARATOR
Intervention: Placebo inhalers (10 types including pMDI, Aerolizer, Handihaler, Turbohaler, Discus, Breezhaler, Ellipta, Easyhaler, Diskhaler, Respimat)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Past-experience
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Inhaler-type
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Gender
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Age category
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: GOLD group
Number of subjects: 180
Study: 32701012

Group type: EXPERIMENTAL
Intervention: OBG 8 times daily for 3 days, followed by 4 times daily for 11 days (Group 1)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: OBG 4 times daily for 14 days (Group 2)
Number of subjects: 45

Group type: COMPARATOR
Intervention: BCL and artificial tears (Control)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: OBG (Groups 1 and 2)
Number of subjects: 45
Study: 33892614

Group type: EXPERIMENTAL
Intervention: Early pushing (allowed to push within one hour after full cervical dilatation)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Delayed pushing (not allowed to push for maximum of three hours)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Delayed pushing
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Early pushing
Number of subjects: 184
Study: 34814921

Group type: EXPERIMENTAL
Intervention: Autologous concentrated growth factor (CGF) after PAOO
Number of subjects: 44

Group type: COMPARATOR
Intervention: Collagen membrane after PAOO
Number of subjects: 44
Study: 35257461

Group type: EXPERIMENTAL
Intervention: iGlarLixi (insulin glargine 100 U/ml + lixisenatide)
Number of subjects: 351

Group type: COMPARATOR
Intervention: GLP-1RA
Number of subjects: 351
Study: 35218726

Group type: EXPERIMENTAL
Intervention: PCE and CAC
Number of subjects: 574

Group type: EXPERIMENTAL
Intervention: PCE and PRS
Number of subjects: 574
Study: 35461642

Group type: EXPERIMENTAL
Intervention: Emotional awareness skills training (once a week for 8 weeks)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 44
Study: 34847158

Group type: EXPERIMENTAL
Intervention: Moving Stories serious game
Number of subjects: 982
Study: 36268677

Group type: EXPERIMENTAL
Intervention: High intensity exercise in the morning
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: High intensity exercise in the afternoon
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Karate specific test (KST)
Number of subjects: 14
Study: 94240848

Group type: EXPERIMENTAL
Intervention: Enalapril (ACE inhibitor)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Sclerotherapy in combination with enalapril
Number of subjects: 21
Study: 36222207

Group type: EXPERIMENTAL
Intervention: Bromocriptine (7.5 mg daily) in group 1 (early-onset androgenic alopecia)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Bromocriptine (7.5 mg daily) in group 2 (normal hair growth)
Number of subjects: 2
Study: 32240760

Group type: EXPERIMENTAL
Intervention: Ticagrelor plus placebo
Number of subjects: 2620

Group type: COMPARATOR
Intervention: Ticagrelor plus aspirin
Number of subjects: 2620

Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy
Number of subjects: 2620
Study: 36215807

Group type: EXPERIMENTAL
Intervention: Required regular switching condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Free-to-choose condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Asked-to-stay condition
Number of subjects: 0
Study: 34338111

Group type: COMPARATOR
Intervention: Statin users (n = 621)
Number of subjects: 2614

Group type: COMPARATOR
Intervention: Hydrophilic statins (n = 37)
Number of subjects: 2614

Group type: COMPARATOR
Intervention: Lipophilic statins (n = 587)
Number of subjects: 2614

Group type: COMPARATOR
Intervention: Non-selective beta-blockers (n = 113)
Number of subjects: 2614

Group type: COMPARATOR
Intervention: Non-selective beta-blockers (n = 40)
Number of subjects: 2614

Group type: COMPARATOR
Intervention: Selective beta-blockers and metformin
Number of subjects: 2614
Study: 32398100

Group type: EXPERIMENTAL
Intervention: TIME trial
Number of subjects: 23